Posts

7 days in healthcare (November 28th-December 4th, 2022

/in /by

 

Summary

From the point of view of biomedicine, the most noteworthy are the debatable but hopeful advances in the treatment of Alzheimer’s, a disease whose treatment has been investigated for many years, without results. A coalition (CEPI) that brings together governments, philanthropic entities and companies, intends to develop future vaccines in 100 days, a third of the record time in which the covid vaccine was developed. The “express” radiotherapy, of milliseconds, a great promise.

As regards Global Health, numerous cases of malaria are detected in Haiti, which had been eradicated three years ago. A mosquito (Anopheles) until now located in Asia, is spreading through Africa, with the risk of increasing malaria, due to its character as a vector of the malaria parasite.

As for international health policy, the most notable is what is happening in China, where, as The Economist says, a health problem is turning into a serious political crisis. In the UK, a negative consequence of Brexit is that the shortage of doctors has worsened.

If we talk about national health policy (Spain), in terms of covid, the incidence is decreasing. What has not just been published is the announced report on the analysis of the management of the crisis. Now it is said that in April, but with the regional and municipal elections in May, we could doubt the date. Harsh criticism of Miguel Sebastián on data management during the pandemic. Serious medical conflict both in Madrid and in the rest of Spain. In addition to job insecurity and poor medical work conditions, there are serious service problems for the population with waiting lists and difficulties in accessing Primary Care. That is the underlying problem, which is very serious, unavoidable and in some cases legitimate political uses on the side. Neither do private doctors seem to be treated very well: low tariffs, which require intensive work, with very little time for patients, are also a problem.

In the field of companies, at the international level we are getting to know Amazon’s most recent commitment to telemedicine a little better, it seems that it focuses on processes that are not very complex and very frequent. It does not seem that he wants to enter the “core” of the difficult health provision. An Alphabet company (Google) advances the use of artificial intelligence for drug discovery. At the national level, it is worth noting the initiatives of ITA, a new unit for neurodevelopmental disorders in Madrid; CASER, with a new residence for the elderly in Majadahonda; and HM Hospitales, which intends to create its own University for doctors.

Biomedicine

Global Health

International Health Policy

National Health Policy

Companies

Korian: a leading multinational for a sector such as nursing homes and mental health care that in our country requires innovation and business muscle

/in /by

 

On May 22, 2022, a breakfast was held at the headquarters of Roland Berger in which Mr. Jaume Raventós, CEO of Korian Spain, acted as a guest. What follows is a summary of his intervention.

The presentation used by Mr. Raventós can be seen below:

Presentacion-Korian-Spain-RB-v3

The Korian group

A large international presence

  • An international group that in 2021 had a turnover of 3.9 billion euros, of which 68% came from residential care; 20% health care; and 12% community care
  • Listed group, operating on the Paris Stock Exchange
  • In residential care it has 721 residences
  • In healthcare 170 facilities
  • In community care, a network of home care, with 194 centers
  • It is a leader in residential care in France, Germany, Belgium and Italy

Main lever of growth

  • The main lever for growth is to offer a continuum of care for an aging and fragile population

Heavy weight on quality control

  • More than 200 people dedicated to quality control
  • Growing weight in its establishments of external accreditations

Type of Korian services

  • Long-term care (nursing homes)
  • Health services
    • Primary Care
    • Specialties and post-acute
  • Community care
    • Home care
    • Residential solutions

Korian has the ambition to create a great mental health group

  • It is already the third group in Spain, with ITA, after the Institut Pere Mata and Domus
  • It is already the third group in France, with the acquisition in 2020 of INCEA
  • The revenue target for 2022 is 250 million euros

Korian is considered a player well positioned for growth

  • Increased demand, with the growth of people over 80 years of age
  • Increased dependency on Europe
  • Very fragmented market
  • Leadership position, with high entry barriers and few actors with scale

Korian values

  • As a service provider for frail people, having strong values ​​is essential
  • Korian’s vision is to provide innovative solutions for a more inclusive society
  • Some recent incidents of other actors in the sector demonstrate the importance of this commitment to values

Korian in Spain

Two great lines of activity

In Spain, Korian has two main lines of activity: nursing homes and mental health services.

Care for the elderly: residences, Seniors

  • 18 accredited residential centers
  • The expected turnover in 2022 is 46 million euros
  • It has more than 2,116 beds and is present in Andalusia, Mallorca, Valencia and Castilla-La Mancha.
  • Has specialized units
    • Behavior Disorder Unit
    • Rehabilitation Unit
    • Alzheimer and Dementia Unit
    • Neurorehabilitation Unit
    • Day Center Unit

Mental Health: ITA

  • Since its foundation in 2016, ITA has been growing rapidly, both organically and inorganically
  • It is organized by specialties
    • Eating disorders, 33% of activity
    • Behavior disorders, 27% of activity
    • Personality disorders, 9% activity
    • General psychiatry, 20% activity
    • Neurodevelopment and rehabilitation: 11% activity
  • It is the largest mental health group in Spain, with more than 5,000 patients a year; more than 38 specialized centers and more than 1,000 professionals
  • Growth is constant, even during the pandemic, with an expected turnover of 58.8 million euros in 2022
  • Incorporates great digital innovation, both in terms of satisfaction surveys, such as patient management and agendas, and in digital therapies
  • ITA has a network of healthcare partners (Quirón, DKV, Vithas, Keralty, etc.) and academic partners (several Universities)

A great growth potential for Korian Spain

  • Without prejudice to the great possibilities for growth in the areas in which Korian is already in Spain (nursing homes and mental health), in relation to Korian’s care offer at a global level, Korian Spain is neither in primary care nor in home care, looming there a great potential for growth

The challenges of the future of care services for vulnerable people

Both the residential and mental care sectors have significant challenges:

General challenges of the sector of vulnerable people

1. Sector concentration vs. fragmentation. Entry of large international groups. Overcoming small-scale farming and professionalization and renewal of the sector.

Senior sector

2. Residential sector, change of model, from large residences of around 200 beds to smaller and more specialized units.

Mental health

3. Financing mental health benefits

    • In the public sector: insufficient means and financing
    • or private sector:
      • Role of health insurers. Insufficient and unspecific coverage (in general, only 20 visits and 30 days of hospitalization). Covering mental health care well is a major challenge for health insurers.
      • School insurance. INSS (1.2 euros/family/year)
      • Possibilities of public/private collaboration. The insufficient means in the public sector and the growing needs offer great possibilities for public collaboration.

 

4. Prevention of mental health problems. Involve the educational system and families

5. Very complicated future due to the lack of professionals. New professional roles. It seems evident that only the development of new professional roles and the promotion of digital therapies will make it possible to advance in this field, where the lack of professionals is frightening and difficult to solve in the short and medium term.

6. Post-COVID stage, until when?

7. The role of digital technology and new surgical and pharmacological therapies